| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 58.72% | 1.36% | -7.03% | 58/140 | 52.37% | 迈克生物 | 57.29% | 行业排名> |
| 2025-12-31 | 63.16% | 1.45% | -0.09% | 52/140 | 51.9% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-09-30 | 63.21% | -3.73% | 1.24% | 49/140 | 52.23% | 佰仁医疗 | 89.18% | 行业排名> |
| 2025-06-30 | 62.44% | -8.35% | 7.79% | 51/140 | 52.43% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-03-31 | 57.93% | -18.32% | -6.95% | 60/140 | 52.13% | 佰仁医疗 | 88.54% | 行业排名> |
| 2024-12-31 | 62.26% | -2.59% | -5.18% | 52/140 | 53.08% | 佰仁医疗 | 85.72% | 行业排名> |
| 2024-09-30 | 65.66% | 9.21% | -3.62% | 45/140 | 53.87% | 佰仁医疗 | 88.34% | 行业排名> |
| 2024-06-30 | 68.13% | 5.24% | -3.94% | 38/140 | 53.95% | 佰仁医疗 | 88.56% | 行业排名> |
| 2024-03-31 | 70.93% | 8.78% | 10.98% | 30/140 | 53.88% | 佰仁医疗 | 89.27% | 行业排名> |
| 2023-12-31 | 63.91% | 5.44% | 6.3% | 48/140 | 53.57% | 佰仁医疗 | 89.28% | 行业排名> |
| 2023-09-30 | 60.12% | -0.89% | -7.12% | 55/140 | 54.44% | 正海生物 | 89.9% | 行业排名> |
| 2023-06-30 | 64.74% | 7.19% | -0.71% | 46/140 | 53.81% | 正海生物 | 90.39% | 行业排名> |
| 2023-03-31 | 65.2% | 2.14% | 7.57% | 44/140 | 54.06% | 正海生物 | 90.3% | 行业排名> |
| 2022-12-31 | 60.62% | -12.32% | -0.08% | 54/140 | 54.01% | 万泰生物 | 91.61% | 行业排名> |
| 2022-09-30 | 60.66% | -15.53% | 0.45% | 53/140 | 55.7% | 三友医疗 | 90.18% | 行业排名> |
| 2022-06-30 | 60.39% | -18.1% | -5.4% | 59/140 | 55.37% | 三友医疗 | 90.14% | 行业排名> |
| 2022-03-31 | 63.84% | -13.28% | -7.66% | 46/140 | 56.89% | 三友医疗 | 90.29% | 行业排名> |
| 2021-12-31 | 69.13% | -10.9% | -3.74% | 40/140 | 57.98% | 三友医疗 | 90.73% | 行业排名> |
| 2021-09-30 | 71.82% | -11.49% | -2.61% | 29/140 | 59.77% | 三友医疗 | 90.5% | 行业排名> |
| 2021-06-30 | 73.74% | -12.28% | 0.17% | 28/140 | 59.05% | 三友医疗 | 90.29% | 行业排名> |
| 2021-03-31 | 73.62% | -16.45% | -5.12% | 27/140 | 61.5% | 正海生物 | 90.78% | 行业排名> |
| 2020-12-31 | 77.59% | -5.1% | -4.37% | 22/140 | 60.12% | 正海生物 | 91.59% | 行业排名> |
| 2020-09-30 | 81.14% | -1.19% | -3.48% | 13/140 | 62.21% | 正海生物 | 92.23% | 行业排名> |
| 2020-06-30 | 84.06% | 2.5% | -4.59% | 9/140 | 60.36% | 正海生物 | 92.69% | 行业排名> |
| 2020-03-31 | 88.11% | 2% | 7.77% | 4/140 | 58.8% | 正海生物 | 92.61% | 行业排名> |
| 2019-12-31 | 81.76% | 0.1% | -0.44% | 15/140 | 56.96% | 正海生物 | 94.38% | 行业排名> |
| 2019-09-30 | 82.12% | 2% | 0.13% | 7/140 | 55.83% | 正海生物 | 93.12% | 行业排名> |
| 2019-06-30 | 82.01% | 2% | 0.42% | 10/140 | 57.93% | 正海生物 | 93.78% | 行业排名> |
| 2018-12-31 | 81.67% | -1.21% | -1.21% | 12/140 | 56.22% | 正海生物 | 93.09% | 行业排名> |
| 2017-12-31 | 82.67% | 1.22% | 1.22% | 9/140 | 56.1% | 正海生物 | 93.85% | 行业排名> |
| 2016-12-31 | 81.68% | 2% | 2% | 11/140 | 57.35% | 正海生物 | 93.08% | 行业排名> |

微信公众号
证券之星APP


